Core Concepts in Pharmacoepidemiology: New‐User Designs
Pharmacoepidemiology and Drug Safety · 2024-12 · 33 (12)
DOI: 10.1002/pds.70048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 25.11.2024. Verfasst von Qoua L Her und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Pharmacoepidemiology. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIA NIH HHS, National Institute on Aging of the National Institutes of Health.
Abstract (Originalsprache)
In this article, we review the history and key reasons for new‐user comparisons in pharmacoepidemiology, highlighting the target trial framework as a unifying framework. We describe three distinct pharmacoepidemiological new‐user study designs: (1) new‐user versus non‐user; (2) active comparator new‐user; (i.e., ACNU) and (3) prevalent new‐user (i.e., PNU) designs, and discuss how each relates to key issues of defining time zero, choosing appropriate comparator groups, and potential sources of bias they do and do not account for. We use a clinical example of hormone replacement therapy and the risk of coronary heart disease to illustrate practical considerations surrounding the application of the three designs presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- GSK, Montreal, Quebec, Canada.
- Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
- Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
ORCID-Profile: John Tazare
Förderung
- Wellcome Trust
- NIA NIH HHS
- National Institute on Aging of the National Institutes of Health
Zitieren
APA
Her, Q. L., Rouette, J., Young, J. C., Webster-Clark, M., & Tazare, J. (2024). Core Concepts in Pharmacoepidemiology: New‐User Designs. Pharmacoepidemiology and Drug Safety, 33(12). https://doi.org/10.1002/pds.70048
Vancouver
Her QL, Rouette J, Young JC, Webster-Clark M, Tazare J. Core Concepts in Pharmacoepidemiology: New‐User Designs. Pharmacoepidemiology and Drug Safety. 2024;33(12). doi:10.1002/pds.70048
BibTeX
@article{Her2024,
author = {Her, Qoua L and Rouette, Julie and Young, Jessica C and Webster-Clark, Michael and Tazare, John},
title = {Core Concepts in Pharmacoepidemiology: New‐User Designs},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
volume = {33},
number = {12},
doi = {10.1002/pds.70048}
}
EUVIMED